Impact of Anticipated Regret Incorporation Into Patient Decision Aids
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02563808|
Recruitment Status : Completed
First Posted : September 30, 2015
Results First Posted : May 31, 2019
Last Update Posted : May 31, 2019
|Condition or disease||Intervention/treatment||Phase|
|Regret||Other: Standard Decision Aid Other: Post-surgical Regret Decision Aid||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||189 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Impact of Anticipated Regret on Decision-Making in Preference Sensitive Care for Breast and Prostate Cancer|
|Study Start Date :||March 2013|
|Actual Primary Completion Date :||February 2014|
|Actual Study Completion Date :||February 2014|
Active Comparator: Standard Decision Aid
The brochure with standard information on surgery for early-stage breast cancer
Other: Standard Decision Aid
Females will receive standard decisions aid for early stage breast cancer.
Experimental: Post-surgical Regret Decision Aid
The brochure that incorporates additional information on the rates of regret after surgical treatment of early-stage breast cancer.
Other: Post-surgical Regret Decision Aid
Females will receive anticipated regret-augmented version for early breast cancer.
- Difference in Consideration of Regret [ Time Frame: 11 months ]Compare decisions about a hypothetical surgery for breast cancer, and examined whether regret is a consideration in treatment decisions between those who received the experimental and those who received the standard version of the decision aid. The values represent numbers of participants who reported that regret played a role in their decision-making.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02563808
|Principal Investigator:||Lee Fleisher, MD||UPenn, Chairman, Anesthesiology & Critical Care|